NeuroCycle Therapeutics uses the latest neuroscience research from leading academic experts to discover and develop new CNS drugs. Our focus is on neuronal ion channels. Selective modulation of these ion channels allows us control dysfunctional neuronal activity without undesirable side effects. Our initial interest is in receptors for the inhibitory neurotransmitters γ-aminobutyric acid (GABA) and glycine. Imbalances towards excessive neuronal excitation leads to a variety of disorders, and our aim is to restore balance by selective inhibition at the site of imbalance.

Our unique biocatalytic medicinal chemistry platform allows us to make drug structures that our competitors can’t. This allows us to realize the full potential of the privileged drug scaffolds that have served as the foundation for numerous important therapeutics.